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Abstract
Background: Primordial germ cells (PGCs) are the embryonic precursors of the sperm and eggs.
Environmental or genetic defects that alter PGC development can impair fertility or cause
formation of germ cell tumors.
Results:  We demonstrate a novel role for cholesterol during germ cell migration in mice.
Cholesterol was measured in living tissue dissected from mouse embryos and was found to
accumulate within the developing gonads as germ cells migrate to colonize these structures.
Cholesterol synthesis was blocked in culture by inhibiting the activity of HMG CoA reductase
(HMGCR) resulting in germ cell survival and migration defects. These defects were rescued by co-
addition of isoprenoids and cholesterol, but neither compound alone was sufficient. In contrast,
loss of the last or penultimate enzyme in cholesterol biosynthesis did not alter PGC numbers or
position in vivo. However embryos that lack these enzymes do not exhibit cholesterol defects at
the stage at which PGCs are migrating. This demonstrates that during gestation, the cholesterol
required for PGC migration can be supplied maternally.
Conclusion: In the mouse, cholesterol is required for PGC survival and motility. It may act cell-
autonomously by regulating clustering of growth factor receptors within PGCs or non cell-
autonomously by controlling release of growth factors required for PGC guidance and survival.
Background
Primordial germ cells (PGCs) are the embryonic precur-
sors of gametes. In most model systems, PGCs are migra-
tory and navigate through or around diverse tissues in
order to find the site of the developing gonads. PGC
migration shares conserved features in many species indi-
cating the process arose in a common ancestor. In verte-
brates, however, the majority of factors implicated in PGC
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guidance are either secreted or membrane bound protein
growth factors (e.g. stromal derived factor 1 and Kit lig-
and); whereas, evidence in Drosophila points to a lipid-
based guidance system [1]. A recent study bridged the gap
by demonstrating that zebrafish PGCs, like Drosophila
PGCs, require 3-hydroxy-3-methylglutaryl-coenzyme A
reductase (HMGCR) for normal migration [2].
HMGCR is the rate limiting enzyme in isoprenoid and
cholesterol biosynthesis. In flies, HMGCR was shown to
act within the somatic gonadal precursors to control
release of a secreted PGC attractant [3]. Drosophila lack
enzymes required downstream of HMGCR for cholesterol
synthesis indicating that isoprenoids are the relevant
downstream effectors [4]. In support of this, Santos and
Lehmann demonstrated that mutations in the geranylger-
anyl transferase 1 β subunit cause PGC migration defects.
It has been proposed that geranylgeranylation of small
GTPase in the Ras, Rac, or Rho families regulate secretion
of hedgehog [5] or other putative Drosophila PGC attract-
ants [4]. In zebrafish, evidence also points to a role for
HMGCR and isoprenoids in PGC migration [2]. Inhibi-
tion of HMGCR or geranylgeranyl transferase I cause PGC
migration defects. However, in this system it remains
unclear whether HMGCR is required in PGCs themselves
or within the soma. Additionally, zebrafish unlike flies are
capable of de novo cholesterol synthesis and this branch
of the pathway was not carefully evaluated.
Cholesterol plays a vital role during vertebrate develop-
ment. Mutations in genes required for cholesterol biosyn-
thesis cause severe developmental defects. Loss of Hmgcr
[6] or squalene synthase [7] result in early embryonic
lethality in mouse models. Mutations in 3b-hydroxysterol-
Δ7 reductase (Dhcr7) or lathosterol 5-desaturase (Sc5d) cause
skeletal, neural, and in some cases urogenital defects in
humans [8] and in mice [9,10]. Additionally, mutations
in genes required for cholesterol transport are also associ-
ated with embryonic lethality or patterning defects [11].
Several models have been evoked in order to explain the
role of cholesterol during organogenesis. First, cholesterol
is the precursor of steroid hormones, glucocorticoids, and
oxysterols, all compounds known to mediate cell-cell sig-
naling via activation of nuclear hormone receptors. Sec-
ond, cholesterol directly regulates cell-cell signalling by
controlling the diffusion [12] or reception [13] of mem-
bers of the hedgehog growth factor family. Finally, choles-
terol is a key structural component of the plasma
membrane. Cholesterol controls membrane fluidity and
modulates membrane protein interactions. Membrane
cholesterol has been shown to influence the activity of
growth factor receptors and cell-adhesion molecules by
clustering these cell surface proteins into lipid rafts [14].
Of particular note, lipid rafts have been shown to affect
epidermal growth factor-induced chemotaxis [15] and
migration on fibronectin [16] in cell culture. This suggests
that cholesterol levels might also alter cell migration in
vivo.
Considering the roles of cholesterol in cell-cell signalling
and cell migration, we thought it imperative to test
whether this branch of the HMGCR pathway is required
for germ cell development in a vertebrate model. In mice,
PGCs migrate from the gut to the genital ridges between
embryonic day 9.5 (E9.5) and E10.5. Steroid hormones
and hedgehog growth factors are unlikely to play a role in
this process. Enzymes required to convert cholesterol into
steroid hormones are not expressed in the gonads until
E11.5 [17]. Likewise, the three vertebrate members of the
hedgehog growth factor family are not expressed in the
right place or time to play a role in PGC guidance in this
system [18,19]. However, changes in cholesterol could
very well impact the ability of PGCs to respond to pro-
posed chemoattractants such as SDF1 [20] or KITL [21].
To examine the role of cholesterol in PGC migration, we
first measured cholesterol in living tissue dissected from
E9.5 embryos and were surprised to find that cholesterol
was enriched in the genital ridges relative to the surround-
ing tissue. This asymmetric distribution appears to be
maintained via selective uptake of cholesterol by cells
within the genital ridges. We further demonstrate that
inhibition of HMGCR reduced total cholesterol and
impaired germ cell survival and migration in culture.
These defects were rescued by co-addition of geranylgera-
niol and cholesterol indicating that both compounds are
required. To test if cholesterol biosynthesis is necessary for
PGC migration in vivo, we examine the number and dis-
tribution of PGCs in embryos lacking Dhcr7 or Sc5d (see
Figure 1). PGCs were normally distributed in both lines,
but cholesterol levels are only modestly affected in these
embryos [9,10]. We conclude that cholesterol is required
for PGC migration but that this requirement can be met
by uptake of cholesterol from maternal sources. We pro-
pose that the asymmetric accumulation of cholesterol
within the genital ridges controls signaling interactions
required for PGCs to colonize the gonads.
Results
Cholesterol is elevated in the genital ridges
Drosophila Hmgcr mRNA is elevated in somatic gonadal
precursors [3] supporting the model that HMGCR acts
non-cell autonomously to guide PGC migration. How-
ever, zebrafish Hmgcr2 is uniformly expressed in cleavage
stage and gastrulating embryos, raising the possibility that
HMGCR has both non-autonomous and autonomous
effects [2]. Like in zebrafish, mouse Hmgcr is ubiquitously
expressed in E10.5 embryos based on in situ hybridization
[22]. However, in situs are not sensitive enough to reveal
modest changes in gene expression. As a more sensitive
technique, quantitative RT-PCR was used to compareBMC Developmental Biology 2008, 8:120 http://www.biomedcentral.com/1471-213X/8/120
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Hmgcr  mRNA levels within the genital ridge and non-
ridge tissue during PGC migration (E9.5) (Figure 2A and
2B). Mouse Hmgcr was uniformly expressed at this stage
confirming the previous in situ hybridization results.
HMGCR activity is controlled by transcriptional and post-
transcriptional mechanisms. For example, cholesterol and
its oxysterol derivatives feedback and inhibit Hmgcr
expression at the transcriptional level [23], while both
steroids and isoprenoids inhibit HMGCR activity by
inducing degradation of the HMGCR protein [24]. There-
fore, the absolute amount of Hmgcr mRNA is unlikely to
be an accurate indicator of the activity of the pathway. The
distribution of cholesterol was examined to provide an
indirect measure of HMGCR pathway activity (Figure 2C–
F). In initial experiments, filipin staining [25] was used to
map the distribution of cholesterol during PGC migration
(Figure 2C and 2D). Filipin is a naturally fluorescent anti-
biotic that binds unesterified cholesterol. Filipin staining
was uniform at E9.5; however we were concerned that fix-
ation and processing (e.g. permeabilization) might have
caused diffusion of cholesterol in the samples. To avoid
processing artifacts, we took advantage of both an electro-
chemical method developed to measure plasma mem-
brane cholesterol levels in living cells [26-28] as well as
time of flight secondary ion mass spectrometry (TOF-
SIMS) [29] (Figure 2E–J). A cholesterol oxidase tipped
bioprobe was used to compare surface cholesterol levels
within the genital ridge and midline tissues (Figure 2E and
2F). Current generated by the probe is proportional to the
cholesterol level at the contact site of the probe which has
a tip diameter of 10 μm. The bioprobe detected a moder-
ate, but consistent elevation of cholesterol within the gen-
ital ridge relative to the midline (gut mesentery). TOF-
SIMS analysis performed on tissue slices that were snap
frozen immediately after dissection did not detect a con-
sistent elevation of cholesterol in the ridges (Figure 2G,
H). However, accumulation of cholesterol in the genital
ridges was detected when the embryonic tissue slice was
incubated for 30 minutes in soluble cholesterol prior to
freezing (Figure 2I and 2J). This suggests that cells within
the genital ridges accumulate high levels of cholesterol via
uptake instead of de novo synthesis. We propose that
localized uptake of cholesterol within the ridge modulates
the signalling interactions required for early development
of the gonad.
Inhibition of HMGCR causes germ cell and somatic cell 
apoptosis
Cells in the developing embryo can obtain cholesterol via
either de novo synthesis or via uptake. This makes it chal-
lenging to manipulate cholesterol levels in utero. To test
the role of cholesterol in PGC migration, we have used an
organ culture system in which PGC containing tissue is
allowed to develop in cholesterol-free media. This elimi-
nates the possibility of uptake from maternal sources and
allows us to manipulate cholesterol levels simply by
inhibiting synthesis. To test the role of cholesterol in PGC
development, tissue slices dissected from E9.5 embryos
were cultured in the presence of statins, drugs that act as
competitive inhibitors of the HMGCR enzyme. Dose
response curves were established for mevinolin, simvasta-
tin and atorvastatin (Figure 3A–C and Additional file 1).
All three statins caused a dose dependent decrease in PGC
numbers after 18 hours. 0.2 μM simvastatin and 1 μM
atorvastatin reduced PGC survival to 80% and 59%
respectively but mevinolin was only effective at compara-
tively high doses. 12 μM mevinolin was the lowest dose of
this drug found to induce a statistically significant drop in
PGC survival. High doses of atorvastatin were toxic. 100
μM atorvastatin reduced PGC survival to 13% (Figure 3C)
and caused sloughing of the somatic cells from the surface
of the tissue slices (Figure 3D and 3E).
The HMGCR pathway Figure 1
The HMGCR pathway. HMGCR is the rate-limiting 
enzyme that converts HMG-CoA into mevalonate. Meval-
onate serves as a precursor for the synthesis of both choles-
terol and isoprenoids. Enzymes inhibited in this study are 
indicated in red.BMC Developmental Biology 2008, 8:120 http://www.biomedcentral.com/1471-213X/8/120
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Cholesterol uptake is elevated in the genitalridges Figure 2
Cholesterol uptake is elevated in the genitalridges. (A) A transverse tissue slice dissected from an E9.5 embryo. Genital 
ridge and non-ridge tissue were isolated as shown. (B) Hmgcr expression in ridge and non-ridge tissue was similar in three inde-
pendent quantitative RT-PCR experiments. Ridge Hmgcr levels were set to an arbitrary value of 100. (C) Unstained (back-
ground fluorescence) and Filipin stained E9.5 tissue. (D) The average filipin staining intensity of midline and ridge tissue was 
calculated by measuring pixel intensity in three midline and three lateral (colored spots in C) regions per slice and normalizing 
to the average ridge staining (set to 100%). (E) A cholesterol bioprobe gave an elevated response when touched to ridge as 
compared to midline tissue. (F) Summary of bioprobe data taken from four slices. Midline response was normalized to the 
ridge response (100%). Scanning TOF-SIMS of an E9.5 slice imaged for (G) phosphatidylcholine (m/z = 184) or (H) cholesterol 
(m/z = 369). E9.5 tissue pre-treated for 30 minutes with soluble cholesterol and imaged for (I) phosphatidylcholine or (J) cho-
lesterol. Arrowheads indicate the position of the genital ridges. In all panels "n" = number of slices and error bars are s.e.m. 
Scale bars are 100 μm.BMC Developmental Biology 2008, 8:120 http://www.biomedcentral.com/1471-213X/8/120
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To examine whether statin-treatment affects total cell sur-
vival, we compared the level of apoptosis in statin treated
and untreated slices (Figure 4). Both atorvastatin and
mevinolin induced a slight increase in PGC apoptosis.
This trend was not statistically significant and may reflect
the fact that immunostaining was performed at the end of
the assay (T18), a timepoint at which many of the PGCs
had already died and been cleared. In support of this, time
lapse analysis of atorvastatin treated slices revealed that
germ cells fragment and disappear at an average rate of 0.8
PGCs per hour (Additional files 2, 3 and 4). PGC apopto-
sis was not elevated in the simvastatin-treated samples
consistent with the weaker effect of this drug on PGC sur-
vival (see Figure 3). However, both simvastatin and
mevinolin caused an increase in somatic cell apoptosis.
Mevinolin-treatment was particularly toxic, causing a two
fold increase in cleaved PARP signal. Of the three statins,
atorvastatin had the most potent and specific effect on
PGCs. The 1 μM dose reduced PGC numbers without
causing an increase in somatic cell apoptosis.
Recent evidence suggests that statins can elicit responses
that are independent of their effects on HMGCR [30].
Additionally, the effects of inhibiting HMGCR itself may
be complex, involving modulation of isoprenoids, choles-
terol or both. To test whether our treatment was effective
at inhibiting HMGCR, we used filipin staining and the
cholesterol oxidase tipped bioprobe to compare choles-
terol levels in atorvastatin-treated and untreated tissue.
Atorvastatin-treatment caused a dose dependent reduc-
tion in both filipin staining and current response (Figure
5). 10 μM atorvastain was the lowest dose capable of caus-
ing a statistically significant drop in cholesterol levels. It is
interesting to note that 1 μM atorvastatin had little effect
on cholesterol levels despite causing a significant reduc-
tion in germ cell numbers. This indicates that germ cells
may be more sensitive to inhibition of HMGCR than the
surrounding tissue.
PGC migration requires both cholesterol and isoprenoids
Rescue experiments were used to test if isoprenoids and
cholesterol have independent roles during PGC migration
(Figure 6). In these rescue experiments, atorvastatin was
used at 10 μM, the lowest dose found to reduce choles-
terol levels in organ culture (Figure 5). Tissue dissected
from E9.5 embryos was treated with atorvastatin alone,
with atorvastatin and isoprenoids (geranylgeraniol or far-
nesol), with atorvastatin and cholesterol, or with atorvas-
tatin, isoprenoids and cholesterol. Cholesterol,
geranylgeraniol or farnesol alone had a very modest and
not statistically significant protective affect (Figure 6A).
However, co-treatment of slices with cholesterol and ger-
anylgeraniol or with cholesterol and farnesol partially res-
cued PGC survival (Figure 6A).
Statin treatment reduces PGC survival Figure 3
Statin treatment reduces PGC survival. PGCs were counted in tissue cultured in (A) mevinolin (B) atorvastatin or (C) 
simvastatin. Average percent survival ± s.e.m. is shown. n = number of slices. "* " = groups that differed from controls. (F < 
0.05 Analysis of Variance from Walpole and Meyer with Fishers least significance post test). (D) A control slice after culture. 
(E) A slice treated with 100 μM atorvastatin. Note sloughing of somatic cells from the surface of the slice. Scale bar is 100 μm.BMC Developmental Biology 2008, 8:120 http://www.biomedcentral.com/1471-213X/8/120
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While performing these experiments, it was noted that sta-
tin-treated slices often had PGCs accumulating on the
midline whereas PGCs in control slices normally cleared
the midline and formed two distinct clusters at the genital
ridges (Figure 6C). Treated slices were filmed and this
effect was found to be caused by a reduction in PGC veloc-
ity (Additional files 2, 3 and 4). Neither cholesterol nor
isoprenoids alone were sufficient to rescue this defect in
PGC motility but co-treatment of slices with both geran-
ylgeraniol and cholesterol was able to rescue this defect
(Figure 6B, E and 6F). Co-treatment with farnesol and
cholesterol did not rescue PGC migration. In fact farnesol
treatment in any combination appeared to inhibit normal
migration (Figure 6B).
De novo cholesterol synthesis is not required for PGC 
migration in vivo
Our in vitro culture data suggests that both isoprenoids
and cholesterol are necessary for PGC survival and motil-
ity. To test the role of cholesterol in germ cell develop-
ment in vivo, we examined the distribution of PGCs in
embryos lacking DHCR7 or lacking SC5D, the last two
enzymes in the cholesterol biosynthetic pathway (Figure
1). These animals exhibit late gestational deficits in cho-
lesterol levels, but are still able to obtain some cholesterol
via uptake from maternal sources. We could not examine
PGCs in animals lacking HMGCR because a loss of this
enzyme results in early embryonic lethality [6]. Animals
lacking DHCR7 die shortly after birth and exhibit reduced
body weight, reduced motility, and a failure to feed [10].
Animals lacking SC5D, the second to last enzyme in cho-
lesterol synthesis are more severely effected. They are still-
born and exhibit skeletal malformations [9].
Gonads were dissected from E12.5 Dhcr7-/-,  Sc5d-/-
embryos and their littermate controls and the numbers of
PGCs compared by immunostaining for SSEA1. There
were no obvious defects in PGC number or position in
these animals (Figure 7). This does not rule out a possible
role for cholesterol in PGC guidance. Dhcr7-/- mice were
shown to have normal liver cholesterol levels at E12.5 and
only exhibit cholesterol deficiency at later stages [10].
Also, Sc5d-/- mice, despite having a more severe spectrum
of malformations than the Dhcr7-/- mice, exhibit similar
Statin treatment induces both somatic cell and germ cell apoptosis Figure 4
Statin treatment induces both somatic cell and germ cell apoptosis. E9.5 tissue was treated with statins, fixed and 
stained for apoptotic cells (cleaved PARP+). (A) The % of apoptotic PGCs (PARP+. GFP+) per slice was calculated. (B) The 
amount of somatic cell apoptosis was compared by summing the pixel intensity of the PARP staining and normalizing to an arbi-
trarily chosen control slice (value set to 1). (C) Apoptosis in a control slice (D) a slice treated with 0.2 μM simvastatin (E) a 
slice treated with 1 μM atorvastatin and (F) a slice treated with 12 μM mevinolin. In all panels "n" = number of slices, error bars 
are s.e.m. and " * " = groups that differed from controls (F < 0.05 Analysis of Variance from Walpole and Meyer with Fishers 
least significance post test). Scale bar is 100 μm.BMC Developmental Biology 2008, 8:120 http://www.biomedcentral.com/1471-213X/8/120
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late gestational reductions in total cholesterol [9]. This
demonstrates that the cholesterol requirement for early
post-implantation development can be provided via the
yolk sac or placenta. Perturbing cholesterol levels during
PGC migration in vivo will require interventions affecting
both synthesis and uptake of cholesterol.
Discussion
This study demonstrates that cholesterol is required for
primordial germ cell survival and motility. Inhibition of
HMGCR reduced cholesterol levels and induced PGC
apoptosis in culture. Addition of cholesterol and farnesol
or cholesterol and geranylgeraniol rescued germ cell sur-
vival; however, PGC motility was only rescued by the lat-
ter combination. Additionally, we found that cholesterol
is elevated in the urogenital ridges and present evidence
that this asymmetric distribution can be maintained by
differential uptake. In support of this, embryos lacking the
last or penultimate enzyme in cholesterol biosynthesis do
not have germ cell defects but these embryos do not
Statin treatment reduces total cholesterol levels Figure 5
Statin treatment reduces total cholesterol levels. (A) Filipin staining of control tissue. Arrow heads indicate autofluo-
rescent cells and arrow indicates lint. (B) Filipin staining of tissue treated with 100 μM atorvastatin. (C) Average filipin staining 
intensity in treated and control slices normalized to control values (set to 100%). (D) Average bioprobe response in treated 
and control tissue normalized to controls (set to 100%). Error bars are s.e.m.. n = number of slices. " * " = groups that differed 
from controls (F < 0.05 Analysis of Variance from Walpole and Meyer with Fishers least significance post test). Scale bar is 100 
μm.BMC Developmental Biology 2008, 8:120 http://www.biomedcentral.com/1471-213X/8/120
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Cholesterol and isoprenoids rescue statin-induced PGC survival and migration defects Figure 6
Cholesterol and isoprenoids rescue statin-induced PGC survival and migration defects. (A) Average PGC survival 
in tissue treated with the indicated combinations of cholesterol (1× concentration), GGOH (pooled data from 10 uM and 20 
uM treatments), FOH (10 uM) and atorvastatin (10 uM). " * " = groups that differed from the atorvastatin group (F < 0.05 Anal-
ysis of Variance from Walpole and Meyer with Fishers least significance post test). (B) The percentage of slices in each treat-
ment group that had two PGC clusters after culture. "*" = groups that differed significantly from the atorvastatin group (exact 
binomial test P-value < 0.05) (C) Control slice that exhibited robust migration (two distinct PGC clusters) and survival (108%). 
(D) Atorvastatin treated slice with scattered PGCs and reduced survival (56%). (E) Slice treated with cholesterol, FOH and 
atorvastatin with excellent survival (100%), but poor migration. (F) Slice treated with atorvastatin, cholesterol and GGOH with 
robust migration and survival (133%). Scale bar is 100 μm. Error bars are s.e.m. n = number of slices.BMC Developmental Biology 2008, 8:120 http://www.biomedcentral.com/1471-213X/8/120
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exhibit cholesterol deficits until late in development
[9,10]. We conclude that the cholesterol requirement for
early developmental processes including PGC migration
can be met by uptake of maternal cholesterol.
HMGCR and isoprenoids are required for migration of
cardiac progenitors and PGCs in both fly and zebrafish
model systems [2,4,31,32]. In these systems, isoprenyla-
tion of heterotrimeric G-protein subunits and/or isopre-
nylaton of small G-proteins in the Ras superfamily are
thought to be altered by loss of HMGCR activity resulting
in the observed developmental phenotype. Our rescue
experiments demonstrate that isoprenoids may play a
similar role during PGC migration in mammals and dem-
onstrate differential roles for GGOH and FOH. Both far-
nesol and geranylgeraniol co-treatments were able to
rescue PGC survival, but only geranylgeraniol co-treat-
ment assisted migration. This probably reflects differen-
tial isoprenylation requirements for different small
GTPase [33]. For instance, Ras proteins are typically far-
nesylated, but when farnesylation is inhibited some Ras
family members can be geranylgeranylated. Likewise, the
small GTPase RhoB can be modified by either isoprenyl
group, but the selection of group has a profound effect on
its subcellular localization and presumably function. We
propose that either farnesylation or geranylgeranylation
can support signalling via a Ras family member involved
in controlling PGC survival or proliferation. However,
geranylgeranyl modification is required to support the
activity of a small GTPase (perhaps in the Rho family)
required for cell motility.
In addition to reflining what has already been shown
about the function of HMGCR and isoprenoids in PGC
development, our data also hints at a function for choles-
terol in PGC survival or motility. A role for cholesterol
during gonadal development is not entirely without prec-
edent. First, genes known to coordinate cholesterol
uptake are elevated within the urogenital ridges (UGRs).
Steroidogenic factor 1 (Nr5a1) is expressed in the UGRs at
E9.5 and its expression becomes confined to the testis by
E12.5. NR5A1 is a member of the nuclear receptor family
and controls expression of genes required for cholesterol
synthesis (HmgCoA synthase) and uptake (Scarb1) as well
as genes required for steroid production [34]. Scarb1
mRNA has been detected in the sexually naive genital
ridge as early as E10.5 and like Nr5a1, it later become
enriched in the testis [17]. Loss of Nr5a1 results in loss of
Scarb1 expression in the UGRs [35] and an absence of
gonads and adrenal glands in both male and female mice
[36]. Second, in the adult ovary, genes required for choles-
terol synthesis are elevated within the granulosa cells sur-
rounding the oocyte and cholesterol synthesized by the
soma helps support oocyte growth by metabolic coupling
[37]. Curiously, migratory PGCs appear to lack meval-
onate kinase and mevalonate decarboxylase enzymes
required for isoprenoid and cholesterol biosynthesis [38].
This suggests that migratory germ cells are already defi-
cient in cholesterol synthesis and may rely on interactions
with the soma to supply their metabolic needs.
Cholesterol alters development via its ability to regulate
cell-cell signaling. Cholesterol is covalently attached to
members of the hedgehog (HH) growth factor family and
this modification controls diffusion of the HH proteins
[12]. Additionally, cholesterol is required for cells to
respond to HH and evidence suggests that it is this process
Loss of de novo cholesterol synthesis does not perturb PGC  migration Figure 7
Loss of de novo cholesterol synthesis does not per-
turb PGC migration. E12.5 gonads from (A) a Dhcr7+/- 
embryo and (B) a Dhcr7-/- littermate. Gonads were stained 
for the PGC marker SSEA1. Similar results were seen for 
four Dhcr7-/- embryos derived from two litters. E12.5 gonads 
dissected from (C) an Sc5d +/- embryo and (D) an Sc5d-/- lit-
termate. Similar results were seen for seven Sc5d-/- embryos 
derived from four litters. Scale bar is 146 μm.BMC Developmental Biology 2008, 8:120 http://www.biomedcentral.com/1471-213X/8/120
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that is perturbed by mutations in Dhcr 7 [13]. In flies, HH
is a proposed attractant for PGCs [39] but in mice, the
expression pattern of hedgehog family members [18,19]
does not suggest a role in PGC guidance. Additionally, a
screen for transcripts expressed in migratory PGCs failed
to detect expression of Gli genes [38] transcription factors
required for HH response. We prefer a model in which
changes in cholesterol alter the secretion or reception of
growth factors known to be required for mammalian PGC
migration. For instance cholesterol rich lipid rafts have
been shown to be required for reception of KITL [40] and
SDF1 [41] growth factors implicated in PGC guidance
[20,21]. Alternatively, the cholesterol rich environment
within the genital ridge might help support PGC survival
via metabolic coupling [37] (Figure 8).
Conclusion
In summary, HMGCR and its downstream products iso-
prenoids and cholesterol are required for mammalian
PGC survival and motility in organ culture. However, in
vivo support for this awaits the development of a system
for efficiently manipulating cholesterol levels in utero.
The role of HMGCR and isoprenoids in PGC migration
has been well established in fly and zebrafish systems but
this is the first study reporting a role for cholesterol in this
process. Additionally, we have demonstrated that choles-
terol preferentially accumulates in the genital ridges. This
observation suggests that cholesterol may play a non-cell
autonomous role in PGC development by either control-
ling secretion of growth factors required for PGC migra-
tion or by regulating development of the somatic support
cells of the gonads. This study provides insight into how
changes in cholesterol (through diet or genetics) might
contribute to changes in development that ultimately
impact fertility later in life.
Methods
Organ culture experiments
All animal procedures were approved by the Case Western
Institutional Animal Care and use Committee. Embryos
heterozygous for the Oct4:ΔPE:GFP germ cell marker were
generated by crossing Oct4:ΔPE:GFP [42] males with CD1
females (Charles River). Embryonic day 0.5 (E0.5) was
assumed to be noon on the day on which a cervical plug
was seen. On E9.5, pregnant females were sedated with
isoflurane and sacrificed by cervical dislocation. The
uterus was removed and placed into phosphate buffered
saline (PBS). Embryos were dissected from the uterus
using forceps and then transferred via pipette into
DMEM/F-12 media (Invitrogen) supplemented with 100
U of penicillin,100 mg streptomycin (Invitrogen) and
0.04%lipid free BSA (Sigma Chem. Co.) (culture media).
Transverse slices approximately 2 somites thick were cut
from the trunk region using a scalpel. Dissected tissue was
placed into organ culture chambers (MiliCel) pre-coated
with collagen IV (Beckton-Dickinson). The culture cham-
bers were incubated overnight at 37°C in 24-well plates
containing 700 ml per well culture media with or without
additives. Atorvastatin (Toronto Research Chemicals),
Simvastatin (EMD Chemicals) and Mevinolin (Sigma
Chem. Co.) stock solutions were prepared in methanol.
Geranylgeraniol (GGOH) (Sigma Chem. Co.) and far-
nesol (Sigma Chem. Co.) stocks were prepared in 2:1
chloroform:methanol. Stock solutions were diluted into
culture media in order to give 10 μM FOH, 10 μM GGOH
or 20 uM GGOH. The 10 uM and 20 uM doses of GGOH
were not found to be statistically different in rescue exper-
iments hence this data was pooled for final analysis.
Where appropriate, a similar amount of carrier (methanol
or chloroform:methanol) was added to the media of the
control samples. Soluble cholesterol (SyntheChol™)
(Sigma Chem. Co.) was purchased and used at 1× work-
ing concentration as per the manufacturer's instructions.
Germ cell numbers were quantified using a Leica TCS SP2
AOBS filter-free Confocal Laser Scanning microscope.
A non-cell autonomous model for the role of cholesterol in  PGC development Figure 8
A non-cell autonomous model for the role of choles-
terol in PGC development. Cholesterol (orange) taken 
up or synthesized by cells of the coelomic epithelium (CE) is 
transferred to PGCs (green). This helps offset the absence of 
metabolic enzymes in PGCs and it facilitates the formation of 
lipid rafts thus amplifying the ability of PGCs to respond to 
locally produced growth factors or chemokines. MM indi-
cates mesonephric mesenchyme and MD the mesonephric 
duct. Large arrow indicates the direction of migration.BMC Developmental Biology 2008, 8:120 http://www.biomedcentral.com/1471-213X/8/120
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Each slice was optically sectioned (at 5 μm intervals) after
0 hours (T0) and eighteen hours (T18) in culture. Germ
cell numbers were counted in the T0 and T18 pictures
using Velocity Image analysis software (Improvision). The
% change in germ cell number for each slice equals T18/
T10*100.
Time lapse analysis
Tissue was cultured at 37°C on the stage of the Leica TCS
SP2 AOBS Confocal system. A single optical section was
captured every 9 minutes for 15 hrs. (100 frames). The
automated tracking feature of Velocity Image analysis
software was used to track PGC movements. Tracking
parameters were as follows. First, PGCs were identified by
percent intensity within the GFP channel (Lower:40
Upper:100). Next, holes were filled in the identified
objects. Touching objects were separated based on size
(using a 100 μm2 size guide). Then any small particles (<
40 μm2) were excluded and large PGC clumps that had
failed to be separated were also excluded (> 300 μm2).
Tracking was performed on the identified objects using
the shortest path algorithm with a maximum of a 10 μm
distance between nodes. Velocity is typically only able to
follow a given cell for part of a movie before it looses track
of the object due to changes in brightness, clumping,
moving out of focus, death etc. To accommodate this, the
resulting traces were sorted based on the length of time
that Velocity was able to follow the individual particles.
Velocity measurements from the 20 temporally longest
traces were averaged to give an average cell velocity for
each film. Average trace times were 3.2 ± 0.17 s.e.m. hours
for control slices (n = 80 traces in four films) and 2.9 ±
0.11 s.e.m. for atorvastatin treated slices (n = 170 traces in
seven films).
Cholesterol measurements
Mouse tissue was fixed in 4% paraformaldehyde in PBS
rocking overnight at 4°C. The tissue was then washed 10
minutes at room temperature in 1.5 mg/mL glycine (in
phosphate buffered saline with 0.1% triton × 100 (PBST))
to block any active aldehyde groups which might other-
wise contribute to autoflourescence. The tissue was rinsed
three times in PBST and rocked overnight at 4°C with
PBST to permeabilize the tissue. Slices were incubated
with 0.05 mg/mL filipin (Sigma Chem. Co.) at room tem-
perature for 30 minutes rocking and were then washed
three times with PBST (15 minute per wash), incubated in
1:1 glycerol:PBS (10 minutes) and mounted in. 4:1 glyc-
erol:PBS (10 minutes). Filipin staining was visualized by
confocal microscopy using the UV laser at 360–370 nm
excitation and 425 nm emission. Filipin staining intensity
was quantified for each slice using Veloocity imaging soft-
ware (Improvision). The background signal (the average
signal of the -filipin slices) was subtracted and the raw sig-
nal normalized to control values (set to 100%).
For bioprobe measurements, platinum microelectrodes
were fabricated in house (11.5 μm and 100 μm diameter
wire, Goodfellow Corp.) as described [26]. Platinum wire
was inserted into glass capillaries (Kimax-51, Kimble
products) and placed inside a heated platinum coil. The
glass was pulled to create a thin insulating layer on the
platinum wire. The capillary microelectrodes were pol-
ished using a beveling machine (WPI, Inc.) to produce a
disk electrode. The microelectrodes were immediately
immersed in a 5 mM hexane solution of 11-mercap-
toundecanoic acid (95%, Aldrich Chem. Co) for 2 hours
to form a carboxylic acid terminated monolayer on the
electrode surface. Then, the microelectrodes were treated
with 2 mM 1-ethyl-3-(3-dimethylaminopropyl) carbodi-
imide (Sigma Chem. Co.) in 100 mM PBS solution (pH
7.4) for 30 minutes to activate the carboxyl groups to an
acylisourea intermediate. The modified electrode was
immersed in 1 mg/ml recombinant cholesterol oxidase
(Oriental Yeast Co. Ltd., 42.0 units/mg) solution for 3
hours allowing this intermediate to react with amine
immobilizing the enzyme on the electrode surface.
Amperometric measurements were conducted using a
two-electrode cell and a voltammeter-amperometer
(Chem-Clamp, Dagan corp.). The three-pole bessel filter
in voltammeter-amperometer was set to 100 Hz. The out-
put was further processed using a noise-rejecting voltme-
ter (model 7310 DSP, Signal Recovery Inc.) to digitally
filter 60-Hz noise. An Ag/AgCl (1 molar KCl) reference
electrode was used for all experiments, and the applied
potential is 780 mV versus the normal hydrogen electrode
for all experiments. All experiments were performed in
100 mM phosphate buffer (pH 7.4) at 36°C. Excised tis-
sue was captured by a capillary prepared in house using an
IM-6 microinjector (Narishige International USA, Inc.).
The electrode was initially positioned about 50 μm from
the tissue for acquisition of baseline data. The electrode
was repositioned for contacting the biological sample and
acquisition of electrode response.
Secondary ion mass spectrometry images were acquired
using a time of flight secondary ion mass spectrometer
(TOF-SIMS) described elsewhere [43]. The instrument uti-
lizes 40 keV C60
+ ion source (Ionoptika, LTD.). The pulsed
primary ion source was operated at an anode voltage of 40
kV angled at 40° to the sample. The beam was focused to
approximately 1 μm in diameter, and delivered 10 pA of
current in 50 ns pulses. Images were acquired by rastering
the pulsed primary ion beam across the sample region
and collecting a mass spectrum for each pixel in the
image. Using imaging software written in-house, mole-
cule-specific images were created by selecting a mass peak
of interest from the summed total mass spectra and plot-
ting the intensity of this mass at each pixel in the image.BMC Developmental Biology 2008, 8:120 http://www.biomedcentral.com/1471-213X/8/120
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SIMS imaging was carried out under ultra high vacuum
requiring that the samples be free of volatile water before
analysis. For this consideration samples were freeze-dried.
Briefly the tissue slices they were rinsed in distilled water,
frozen in liquid N2 and fixed to a copper sample stub,
which was also cooled to liquid N2 temperature. The stub
and the sample were entered into vacuum chamber (10-8
torr) and allowed to warm for several hours until all the
water had sublimed.
Whole-mount immunostaining
E9.5 slices or E12.5 whole embryos were fixed in 8% para-
formaldehyde in PBS rocking overnight at 4°C. The tissue
was rinsed three times in PBST and the embryonic gonads
were removed from the E12.5 samples. Tissue slices or
whole gonads were permeabilized overnight at 4°C in
PBST. Tissue was then blocked overnight at 4°C in 2%
goat serum/2% Ig-G free BSA (Jackson Immuno Research)
in PBST. Samples were then incubated at 4°C overnight in
primary antibodies (1:100 anti-cleaved PARP) (Cell Sign-
aling Technology), or 1:500 SSEA1 (Developmental Stud-
ies Hybridoma Bank)) diluted in block followed by five 1
hour room temperature washes with PBST. Samples were
incubated at 4°C overnight in 1:200 dilution of secondary
antibodies (goat anti-rabbit IgG Cy5 or goat anti-mouse
IgM AlexaFluor 647) (Jackson Immuno Research) in
block followed by five 1 hour room temperature washes
with PBST. The tissue was then cleared by incubation in
1:1 glycerol:PBS (10 minutes) followed by 4:1 glyc-
erol:PBS (10 minutes) and mounted in Vectashield
mounting media. Samples were left overnight at 4°C to
allow the Vectashield to completely penetrate and then
the staining was visualized using confocal microscopy.
For long-term storage of some whole embryo samples, the
tissue was dehydrated through a methanol series and
stored at -20°C prior to the antibody staining procedure
described above. Methanol treatment did not adversely
affect either cleaved PARP staining or SSEA1 staining.
RT-PCR for HMGCR mRNA
Quantitative RT-PCR was performed as described [44].
Briefly, total mRNA was isolated from mouse tissue using
TRIzol (Invitrogen) and linear polyacrylamide (Sigma
Chem Co.) as a carrier. cDNA was prepared using the
Superscript III kit (Invitrogen). Primers against Hmgcr (F:
CACCTCTCCGTGGG TTAAAA and R: GAAGAAGTAG-
GCCCCCAATC), Tata-binding protein (F: CTTCGTGCAA-
GAAATGCTGA and R:AGAACTTAGCTGGGAAGCCC)
and  β-Actin (F: AGAGGGAAATCGTGCGTGAC and R:
CAATAGTGATGACCTGGCCGT) were designed using
Primer 3 http://frodo.wi.mit.edu/. The genital ridge cDNA
was left undiluted or diluted 1:2 and 1:10 to generate a 3
point standard curve corresponding to 100, 50 and 10
arbitrary expression units. The relative expression level of
Hmgcr and loading controls (Tata-binding protein and β-
actin) in the non genital ridge tissue was compared to the
genital ridge standard curve using real time PCR. Quanti-
Tect SYBR Green Mix (Qiagen) was used as a source of
Taq, Buffer and dNTPs. The Chromo4 system (MJ
Research) was used to perform the cycling, fluorescent
measurements and melting curves. Cycling conditions
were 1) 95°C for 15 minutes, 2) 40× (denature (95°C 30
sec), anneal (51°C 30 sec.), extend (72°C 30 seconds),
plate read (74°C for 30 seconds followed by plate read))
3) incubate at 72°C for 5 minutes, 4) melting curve from
70°C to 95°C, read every 1°C. Raw expression units for
Hmgcr were normalized using the average of the loading
controls (tata-binding protein and β-actin).
Abbreviations
BSA: bovine serum albumin; DHCR7: 3b-hydroxysterol-
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ylglutaryl-coenzyme A reductase; KITL: kit ligand; NR5A1:
steroidogenic factor 1; PARP: poly(ADP-ribose) polymer-
ase 1; PBS:phosphate buffered saline; PGC: primordial
germ cell; RT-PCR: real time polymerase chain reaction;
SC5D: lathosterol 5-desaturase; SCARB1: scavenger recep-
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SIMS: time of flight secondary ion mass spectrometry;
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